These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Zhou J, Dutch RE, Lamb RA. Virology; 1997 Dec 22; 239(2):327-39. PubMed ID: 9434724 [Abstract] [Full Text] [Related]
12. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor. Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M. Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053 [Abstract] [Full Text] [Related]
13. Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. Caffrey M, Cai M, Kaufman J, Stahl SJ, Wingfield PT, Covell DG, Gronenborn AM, Clore GM. EMBO J; 1998 Aug 17; 17(16):4572-84. PubMed ID: 9707417 [Abstract] [Full Text] [Related]
18. Atomic structure of the ectodomain from HIV-1 gp41. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. Nature; 1997 May 22; 387(6631):426-30. PubMed ID: 9163431 [Abstract] [Full Text] [Related]
19. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors. Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R. J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018 [Abstract] [Full Text] [Related]
20. Antiviral properties of two trimeric recombinant gp41 proteins. Delcroix-Genête D, Quan PL, Roger MG, Hazan U, Nisole S, Rousseau C. Retrovirology; 2006 Mar 03; 3():16. PubMed ID: 16515685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]